Informations:
Erreur:
Mots-clés
TNM staging ×
- Clinical Trial (6)
- Lymphoma, Non-Hodgkin (4)
- Laboratories (3)
- Scores & Instruments (2)
- Hematology (2)
- Hodgkin Disease (2)
- Multiple Myeloma (2)
- Physical Examination (1)
- Lymphoma, B-Cell (1)
- Radioimmunotherapy (1)
- Peripheral Blood Stem Cell Transplantation (1)
- Positron-Emission Tomography (1)
- Routine documentation (1)
- Follow-Up Studies (1)
- Lymph Nodes (1)
- Medical Oncology (1)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
10 Résultats de recherche.
Groupes Item: EBMT FORM GENERAL INFORMATION, PATIENT, DISEASE, PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA), PRE-HSCT TREATMENT, HSCT, STATUS OF DISEASE AT COLLECTION, DISEASE STATUS AT HSCT, ADDITIONAL TREATMENT POST-HSCT, STATUS OF DISEASE AT 100 DAYS AFTER HSCT, FORMS TO BE FILLED IN, PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA), PATIENT LAST SEEN, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, OTHER COMPLICATIONS SINCE LAST REPORT, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT, LAST DISEASE AND PATIENT STATUS
Groupes Item: Form Header, Laboratory, Nodal involvement, Organ involvement, Lymph node size after Chemotherapy, Examinations, Best response, Comments
Groupes Item: Form Header, Nodal involvement, Organ involvement, Examinations, MRI instead of CT, Other examinations, Risk factors, Ann-Arbor Staging, Comments
Groupes Item: Patient demographics, Therapy, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, IPI, Footer module
Groupes Item: Monthly control visit with response evaluation, Parameter of multiple myeloma, Vital signs, Laboratory:Protein electrophoresis, Laboratory:Hematology, Laboratory:serum chemistry, Laboratory:pregnancy test, Quality of life
Groupes Item: Administrative Data, Diagnostic Imaging, Head/Neck, Diagnostic Imaging; Chest, Diagnostic Imaging, Abdomen, Diagnostic Imaging, Pelvis, Diagnostic Imaging, Other, Bone Marrow Biopsy, Measurable Lymphoma Disease, Non-Measurable Disease
Groupes Item: General health, Time of follow-up, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, Footer module
Groupes Item: Patient demographics, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, Dscontinuation of therapy, IPI, Footer module
Groupes Item: Administrative, Physical Examination (Baseline), Physical Examination (Baseline) , Laboratory Results (Baseline) - Hematology, Laboratory Results (Baseline) - Hematology, Laboratory Results (Baseline) - Chemistry, Laboratory Results (Baseline) - Chemistry, Pregnancy Test (Baseline), Disease Staging - CT or other Radiological Imaging Results (Baseline), Disease Staging - Bone Marrow Biopsy (Baseline), Disease Staging - Measurable Lymphoma Disease (Baseline), Disease Staging - Non-Measurable Lymphoma Disease (Baseline) , Disease Staging - Non-Measurable Lymphoma Disease (Baseline) , Signature of Investigator
Groupes Item: CT or other Radiological Imaging Results, Bone Marrow Biopsy, Measurable Lymphoma Disease, Non-Measurable Dlsease, Administration, Laboratory Results